Novel cancer stem cell killing agent for gastric cancer and application thereof
The invention discloses a novel application of a lipid-lowering drug Evacetrapib in the treatment of gastric cancer tumor stem cells. Using gastric cancer stem cells as a model, we found that Evacetrapib could not only inhibit the growth of gastric cancer cell line, but also promote its apoptosis. I...
Saved in:
Main Authors | , , , , , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
18.01.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!